{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:40:08Z","timestamp":1761946808744},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T00:00:00Z","timestamp":1512432000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Front. Med."],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1007\/s11684-017-0581-0","type":"journal-article","created":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T06:06:11Z","timestamp":1512453971000},"page":"229-235","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Molecular classification and precision therapy of cancer: immune checkpoint inhibitors"],"prefix":"10.1007","volume":"12","author":[{"given":"Yingyan","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,5]]},"reference":[{"issue":"7","key":"581_CR1","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1016\/j.ajpath.2016.02.023","volume":"186","author":"BVSK Chakravarthi","year":"2016","unstructured":"Chakravarthi BVSK, Nepal S, Varambally S. Genomic and epigenomic alterations in cancer. Am J Pathol 2016; 186(7): 1724\u20131735","journal-title":"Am J Pathol"},{"issue":"4","key":"581_CR2","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.cell.2014.06.049","volume":"158","author":"KA Hoadley","year":"2014","unstructured":"Hoadley KA, Yau C, Wolf DM, Cherniack AD, Tamborero D, Ng S, Leiserson MD, Niu B, McLellan MD, Uzunangelov V, Zhang J, Kandoth C, Akbani R, Shen H, Omberg L, Chu A, Margolin AA, Van\u2019t Veer LJ, Lopez-Bigas N, Laird PW, Raphael BJ, Ding L, Robertson AG, Byers LA, Mills GB, Weinstein JN, Van Waes C, Chen Z, Collisson EA; Cancer Genome Atlas Research Network, Benz CC, Perou CM, Stuart JM. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. Cell 2014; 158(4): 929\u2013944","journal-title":"Cell"},{"issue":"7528","key":"581_CR3","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/nature14011","volume":"515","author":"RS Herbst","year":"2014","unstructured":"Herbst RS, Soria JC, Kowanetz M, Fine GD, Hamid O, Gordon MS, Sosman JA, McDermott DF, Powderly JD, Gettinger SN, Kohrt HE, Horn L, Lawrence DP, Rost S, Leabman M, Xiao Y, Mokatrin A, Koeppen H, Hegde PS, Mellman I, Chen DS, Hodi FS. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature 2014; 515(7528): 563\u2013567","journal-title":"Nature"},{"issue":"3","key":"581_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1007\/s12032-015-0501-6","volume":"32","author":"J Zhang","year":"2015","unstructured":"Zhang J, Fang W, Qin T, Yang Y, Hong S, Liang W, Ma Y, Zhao H, Huang Y, Xue C, Huang P, Hu Z, Zhao Y, Zhang L. Co-expression of PD-1 and PD-L1 predicts poor outcome in nasopharyngeal carcinoma. Med Oncol 2015; 32(3): 86","journal-title":"Med Oncol"},{"issue":"7547","key":"581_CR5","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature14292","volume":"520","author":"C Twyman-Saint Victor","year":"2015","unstructured":"Twyman-Saint Victor C, Rech AJ, Maity A, Rengan R, Pauken KE, Stelekati E, Benci JL, Xu B, Dada H, Odorizzi PM, Herati RS, Mansfield KD, Patsch D, Amaravadi RK, Schuchter LM, Ishwaran H, Mick R, Pryma DA, Xu X, Feldman MD, Gangadhar TC, Hahn SM, Wherry EJ, Vonderheide RH, Minn AJ. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer. Nature 2015; 520(7547): 373\u2013377","journal-title":"Nature"},{"issue":"26","key":"581_CR6","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","volume":"366","author":"JR Brahmer","year":"2012","unstructured":"Brahmer JR, Tykodi SS, Chow LQ, Hwu WJ, Topalian SL, Hwu P, Drake CG, Camacho LH, Kauh J, Odunsi K, Pitot HC, Hamid O, Bhatia S, Martins R, Eaton K, Chen S, Salay TM, Alaparthy S, Grosso JF, Korman AJ, Parker SM, Agrawal S, Goldberg SM, Pardoll DM, Gupta A, Wigginton JM. Safety and activity of anti- PD-L1 antibody in patients with advanced cancer. N Engl J Med 2012; 366(26): 2455\u20132465","journal-title":"N Engl J Med"},{"issue":"3","key":"581_CR7","first-page":"15","volume":"28","author":"JW Kim","year":"2014","unstructured":"Kim JW, Eder JP. Prospects for targeting PD-1 and PD-L1 in various tumor types. Oncology (Williston Park) 2014; 28(Suppl 3): 15\u201328","journal-title":"Oncology (Williston Park)"},{"issue":"6","key":"581_CR8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/1756287215597647","volume":"7","author":"M Weinstock","year":"2015","unstructured":"Weinstock M, McDermott D. Targeting PD-1\/PD-L1 in the treatment of metastatic renal cell carcinoma. Ther Adv Urol 2015; 7(6): 365\u2013377","journal-title":"Ther Adv Urol"},{"issue":"19","key":"581_CR9","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-13-3271","volume":"20","author":"JM Taube","year":"2014","unstructured":"Taube JM, Klein A, Brahmer JR, Xu H, Pan X, Kim JH, Chen L, Pardoll DM, Topalian SL, Anders RA. Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy. Clin Cancer Res 2014; 20(19): 5064\u20135074","journal-title":"Clin Cancer Res"},{"issue":"17","key":"581_CR10","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","volume":"33","author":"MA Postow","year":"2015","unstructured":"Postow MA, Callahan MK, Wolchok JD. Immune checkpoint blockade in cancer therapy. J Clin Oncol 2015; 33(17): 1974\u20131982","journal-title":"J Clin Oncol"},{"issue":"4","key":"581_CR11","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.molmed.2016.02.003","volume":"22","author":"SK Li","year":"2016","unstructured":"Li SK, Martin A. Mismatch repair and colon cancer: mechanisms and therapies explored. Trends Mol Med 2016; 22(4): 274\u2013289","journal-title":"Trends Mol Med"},{"issue":"1","key":"581_CR12","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1158\/2159-8290.CD-14-0863","volume":"5","author":"NJ Llosa","year":"2015","unstructured":"Llosa NJ, Cruise M, Tam A, Wicks EC, Hechenbleikner EM, Taube JM, Blosser RL, Fan H, Wang H, Luber BS, Zhang M, Papadopoulos N, Kinzler KW, Vogelstein B, Sears CL, Anders RA, Pardoll DM, Housseau F. The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints. Cancer Discov 2015; 5(1): 43\u201351","journal-title":"Cancer Discov"},{"issue":"4","key":"581_CR13","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1158\/1078-0432.CCR-15-1678","volume":"22","author":"JC Dudley","year":"2016","unstructured":"Dudley JC, Lin MT, Le DT, Eshleman JR. Microsatellite instability as a biomarker for PD-1 blockade. Clin Cancer Res 2016; 22(4): 813\u2013820","journal-title":"Clin Cancer Res"},{"issue":"7","key":"581_CR14","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1101\/gr.145706.112","volume":"23","author":"K Yoon","year":"2013","unstructured":"Yoon K, Lee S, Han TS, Moon SY, Yun SM, Kong SH, Jho S, Choe J, Yu J, Lee HJ, Park JH, Kim HM, Lee SY, Park J, Kim WH, Bhak J, Yang HK, Kim SJ. Comprehensive genome- and transcriptomewide analyses of mutations associated with microsatellite instability in Korean gastric cancers. Genome Res 2013; 23(7): 1109\u20131117","journal-title":"Genome Res"},{"issue":"4","key":"581_CR15","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.3892\/ijo.2015.3119","volume":"47","author":"S Richman","year":"2015","unstructured":"Richman S. Deficient mismatch repair: read all about it. Int J Oncol 2015; 47(4): 1189\u20131202","journal-title":"Int J Oncol"},{"issue":"4","key":"581_CR16","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s10120-012-0226-6","volume":"16","author":"T Arai","year":"2013","unstructured":"Arai T, Sakurai U, Sawabe M, Honma N, Aida J, Ushio Y, Kanazawa N, Kuroiwa K, Takubo K. Frequent microsatellite instability in papillary and solid-type, poorly differentiated adenocarcinomas of the stomach. Gastric Cancer 2013; 16(4): 505\u2013512","journal-title":"Gastric Cancer"},{"issue":"12","key":"581_CR17","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1111\/j.1572-0241.2006.00845.x","volume":"101","author":"FA Sinicrope","year":"2006","unstructured":"Sinicrope FA, Rego RL, Foster N, Sargent DJ, Windschitl HE, Burgart LJ, Witzig TE, Thibodeau SN. Microsatellite instability accounts for tumor site-related differences in clinicopathologic variables and prognosis in human colon cancers. Am J Gastroenterol 2006; 101(12): 2818\u20132825","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"581_CR18","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1097\/AOG.0b013e31817051d9","volume":"111","author":"KS Matthews","year":"2008","unstructured":"Matthews KS, Estes JM, Conner MG, Manne U, Whitworth JM, Huh WK, Alvarez RD, Straughn JM Jr, Barnes MN, Rocconi RP. Lynch syndrome in women less than 50 years of age with endometrial cancer. Obstet Gynecol 2008; 111(5): 1161\u20131166","journal-title":"Obstet Gynecol"},{"issue":"35","key":"581_CR19","doi-asserted-by":"publisher","first-page":"4409","DOI":"10.1200\/JCO.2012.43.2278","volume":"30","author":"C Engel","year":"2012","unstructured":"Engel C, Loeffler M, Steinke V, Rahner N, Holinski-Feder E, Dietmaier W, Schackert HK, Goergens H, von Knebel Doeberitz M, Goecke TO, Schmiegel W, Buettner R, Moeslein G, Letteboer TG, G\u00f3mez Garc\u00eda E, Hes FJ, Hoogerbrugge N, Menko FH, van Os TA, Sijmons RH, Wagner A, Kluijt I, Propping P, Vasen HF. Risks of less common cancers in proven mutation carriers with lynch syndrome. J Clin Oncol 2012; 30(35): 4409\u20134415","journal-title":"J Clin Oncol"},{"issue":"2","key":"581_CR20","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1002\/ijc.23508","volume":"123","author":"P Watson","year":"2008","unstructured":"Watson P, Vasen HF, Mecklin JP, Bernstein I, Aarnio M, J\u00e4rvinen HJ, Myrh\u00f8j T, Sunde L, Wijnen JT, Lynch HT. The risk of extracolonic, extra-endometrial cancer in the Lynch syndrome. Int J Cancer 2008; 123(2): 444\u2013449","journal-title":"Int J Cancer"},{"issue":"2","key":"581_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0165-4608(97)00452-4","volume":"104","author":"VR Talwalkar","year":"1998","unstructured":"Talwalkar VR, Scheiner M, Hedges LK, Butler MG, Schwartz HS. Microsatellite instability in malignant melanoma. Cancer Genet Cytogenet 1998; 104(2): 111\u2013114","journal-title":"Cancer Genet Cytogenet"},{"issue":"1","key":"581_CR22","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1046\/j.0022-202x.2001.01611.x","volume":"118","author":"E Alvino","year":"2002","unstructured":"Alvino E, Marra G, Pagani E, Falcinelli S, Pepponi R, Perrera C, Haider R, Castiglia D, Ferranti G, Bonmassar E, Jiricny J, Zambruno G, D\u2019Atri S. High-frequency microsatellite instability is associated with defective DNA mismatch repair in human melanoma. J Invest Dermatol 2002; 118(1): 79\u201386","journal-title":"J Invest Dermatol"},{"issue":"2","key":"581_CR23","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/00008390-200304000-00009","volume":"13","author":"G Palmieri","year":"2003","unstructured":"Palmieri G, Ascierto PA, Cossu A, Colombino M, Casula M, Botti G, Lissia A, Tanda F, Castello G. Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign naevi, dysplastic naevi, and primary melanomas and their metastases. Melanoma Res 2003; 13(2): 167\u2013170","journal-title":"Melanoma Res"},{"issue":"3","key":"581_CR24","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.surg.2005.08.021","volume":"139","author":"S Beghelli","year":"2006","unstructured":"Beghelli S, de Manzoni G, Barbi S, Tomezzoli A, Roviello F, Di Gregorio C, Vindigni C, Bortesi L, Parisi A, Saragoni L, Scarpa A, Moore PS. Microsatellite instability in gastric cancer is associated with better prognosis in only stage II cancers. Surgery 2006; 139(3): 347\u2013356","journal-title":"Surgery"},{"issue":"9","key":"581_CR25","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1007\/s00268-012-1652-7","volume":"36","author":"WL Fang","year":"2012","unstructured":"Fang WL, Chang SC, Lan YT, Huang KH, Chen JH, Lo SS, Hsieh MC, Li AF, Wu CW, Chiou SH. Microsatellite instability is associated with a better prognosis for gastric cancer patients after curative surgery. World J Surg 2012; 36(9): 2131\u20132138","journal-title":"World J Surg"},{"issue":"6","key":"581_CR26","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/modpathol.3880578","volume":"15","author":"HS Lee","year":"2002","unstructured":"Lee HS, Choi SI, Lee HK, Kim HS, Yang HK, Kang GH, Kim YI, Lee BL, Kim WH. Distinct clinical features and outcomes of gastric cancers with microsatellite instability. Mod Pathol 2002; 15(6): 632\u2013640","journal-title":"Mod Pathol"},{"issue":"10027","key":"581_CR27","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1016\/S0140-6736(15)01281-7","volume":"387","author":"RS Herbst","year":"2016","unstructured":"Herbst RS, Baas P, Kim DW, Felip E, P\u00e9rez-Gracia JL, Han JY, Molina J, Kim JH, Arvis CD, Ahn MJ, Majem M, Fidler MJ, de Castro G Jr, Garrido M, Lubiniecki GM, Shentu Y, Im E, Dolled-Filhart M, Garon EB. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial. Lancet 2016; 387(10027): 1540\u20131550","journal-title":"Lancet"},{"issue":"16","key":"581_CR28","doi-asserted-by":"publisher","first-page":"4938","DOI":"10.1158\/1078-0432.CCR-16-1821","volume":"23","author":"JC Sunshine","year":"2017","unstructured":"Sunshine JC, Nguyen PL, Kaunitz GJ, Cottrell TR, Berry S, Esandrio J, Xu H, Ogurtsova A, Bleich KB, Cornish TC, Lipson EJ, Anders RA, Taube JM. PD-L1 expression in melanoma: a quantitative immunohistochemical antibody comparison. Clin Cancer Res 2017; 23(16):4938\u20134944","journal-title":"Clin Cancer Res"},{"issue":"1","key":"581_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13045-016-0277-y","volume":"9","author":"W Ma","year":"2016","unstructured":"Ma W, Gilligan BM, Yuan J, Li T. Current status and perspectives in translational biomarker research for PD-1\/PD-L1 immune checkpoint blockade therapy. J Hematol Oncol 2016; 9(1): 47","journal-title":"J Hematol Oncol"},{"issue":"21","key":"581_CR30","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1056\/NEJMoa1501824","volume":"372","author":"EB Garon","year":"2015","unstructured":"Garon EB, Rizvi NA, Hui R, Leighl N, Balmanoukian AS, Eder JP, Patnaik A, Aggarwal C, Gubens M, Horn L, Carcereny E, Ahn MJ, Felip E, Lee JS, Hellmann MD, Hamid O, Goldman JW, Soria JC, Dolled-Filhart M, Rutledge RZ, Zhang J, Lunceford JK, Rangwala R, Lubiniecki GM, Roach C, Emancipator K, Gandhi L; KEYNOTE-001 Investigators. Pembrolizumab for the treatment of nonsmall-cell lung cancer. N Engl J Med 2015; 372(21): 2018\u20132028","journal-title":"N Engl J Med"},{"issue":"3","key":"581_CR31","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1053\/j.gastro.2013.12.002","volume":"146","author":"AR Mensenkamp","year":"2014","unstructured":"Mensenkamp AR, Vogelaar IP, van Zelst-Stams WA, Goossens M, Ouchene H, Hendriks-Cornelissen SJ, Kwint MP, Hoogerbrugge N, Nagtegaal ID, Ligtenberg MJ. Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors. Gastroenterology 2014; 146(3): 643\u2013646.e8","journal-title":"Gastroenterology"},{"issue":"4","key":"581_CR32","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1365-2559.2011.04021.x","volume":"60","author":"W Fadhil","year":"2012","unstructured":"Fadhil W, Ilyas M. Immunostaining for mismatch repair (MMR) protein expression in colorectal cancer is better and easier to interpret when performed on diagnostic biopsies. Histopathology 2012; 60(4): 653\u2013655","journal-title":"Histopathology"},{"issue":"12","key":"581_CR33","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1097\/PAS.0b013e3181f906cc","volume":"34","author":"F Bao","year":"2010","unstructured":"Bao F, Panarelli NC, Rennert H, Sherr DL, Yantiss RK. Neoadjuvant therapy induces loss of MSH6 expression in colorectal carcinoma. Am J Surg Pathol 2010; 34(12): 1798\u20131804","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"581_CR34","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1093\/jnci\/djk033","volume":"99","author":"RM Xicola","year":"2007","unstructured":"Xicola RM, Llor X, Pons E, Castells A, Alenda C, Pi\u00f1ol V, Andreu M, Castellv\u00ed-Bel S, Pay\u00e1 A, Jover R, Bessa X, Gir\u00f3s A, Duque JM, Nicol\u00e1s-P\u00e9rez D, Garcia AM, Rigau J, Gassull MA; Gastrointestinal Oncology Group of the Spanish Gastroenterological Association. Performance of different microsatellite marker panels for detection of mismatch repair-deficient colorectal tumors. J Natl Cancer Inst 2007; 99(3): 244\u2013252","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"581_CR35","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1158\/1055-9965.EPI-08-0878","volume":"18","author":"B Bapat","year":"2009","unstructured":"Bapat B, Lindor NM, Baron J, Siegmund K, Li L, Zheng Y, Haile R, Gallinger S, Jass JR, Young JP, Cotterchio M, Jenkins M, Grove J, Casey G, Thibodeau SN, Bishop DT, Hopper JL, Ahnen D, Newcomb PA, Le Marchand L, Potter JD, Seminara D; Colon Cancer Family Registry. The association of tumor microsatellite instability phenotype with family history of colorectal cancer. Cancer Epidemiol Biomarkers Prev 2009; 18(3): 967\u2013975","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7517","key":"581_CR36","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Cancer Genome Atlas Research Network.","year":"2014","unstructured":"Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature 2014; 513(7517): 202\u2013209","journal-title":"Nature"},{"issue":"9","key":"581_CR37","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1056\/NEJMe1606042","volume":"375","author":"CB Bifulco","year":"2016","unstructured":"Bifulco CB, Urba WJ. Unmasking PD-1 resistance by nextgeneration sequencing. N Engl J Med 2016; 375(9): 888\u2013889","journal-title":"N Engl J Med"},{"issue":"1","key":"581_CR38","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2016.02.065","volume":"165","author":"W Hugo","year":"2016","unstructured":"Hugo W, Zaretsky JM, Sun L, Song C, Moreno BH, Hu-Lieskovan S, Berent-Maoz B, Pang J, Chmielowski B, Cherry G, Seja E, Lomeli S, Kong X, Kelley MC, Sosman JA, Johnson DB, Ribas A, Lo RS. Genomic and transcriptomic features of response to anti-PD-1 therapy in metastatic melanoma. Cell 2016; 165(1): 35\u201344","journal-title":"Cell"},{"issue":"7559","key":"581_CR39","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature14404","volume":"523","author":"S Spranger","year":"2015","unstructured":"Spranger S, Bao R, Gajewski TF. Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity. Nature 2015; 523(7559): 231\u2013235","journal-title":"Nature"},{"issue":"2","key":"581_CR40","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1158\/2159-8290.CD-15-0283","volume":"6","author":"W Peng","year":"2016","unstructured":"Peng W, Chen JQ, Liu C, Malu S, Creasy C, Tetzlaff MT, Xu C, McKenzie JA, Zhang C, Liang X, Williams LJ, Deng W, Chen G, Mbofung R, Lazar AJ, Torres-Cabala CA, Cooper ZA, Chen PL, Tieu TN, Spranger S, Yu X, Bernatchez C, Forget MA, Haymaker C, Amaria R, McQuade JL, Glitza IC, Cascone T, Li HS, Kwong LN, Heffernan TP, Hu J, Bassett RL Jr, Bosenberg MW, Woodman SE, Overwijk WW, Liz\u00e9e G, Roszik J, Gajewski TF, Wargo JA, Gershenwald JE, Radvanyi L, Davies MA, Hwu P. Loss of PTEN promotes resistance to T cell-mediated immunotherapy. Cancer Discov 2016; 6(2): 202\u2013216","journal-title":"Cancer Discov"},{"issue":"9","key":"581_CR41","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJMoa1604958","volume":"375","author":"JM Zaretsky","year":"2016","unstructured":"Zaretsky JM, Garcia-Diaz A, Shin DS, Escuin-Ordinas H, Hugo W, Hu-Lieskovan S, Torrejon DY, Abril-Rodriguez G, Sandoval S, Barthly L, Saco J, Homet Moreno B, Mezzadra R, Chmielowski B, Ruchalski K, Shintaku IP, Sanchez PJ, Puig-Saus C, Cherry G, Seja E, Kong X, Pang J, Berent-Maoz B, Comin-Anduix B, Graeber TG, Tumeh PC, Schumacher TN, Lo RS, Ribas A. Mutations associated with acquired resistance to PD-1 blockade in melanoma. N Engl J Med 2016; 375(9): 819\u2013829","journal-title":"N Engl J Med"},{"issue":"6349","key":"581_CR42","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, Lu S, Kemberling H, Wilt C, Luber BS, Wong F, Azad NS, Rucki AA, Laheru D, Donehower R, Zaheer A, Fisher GA, Crocenzi TS, Lee JJ, Greten TF, Duffy AG, Ciombor KK, Eyring AD, Lam BH, Joe A, Kang SP, Holdhoff M, Danilova L, Cope L, Meyer C, Zhou S, Goldberg RM, Armstrong DK, Bever KM, Fader AN, Taube J, Housseau F, Spetzler D, Xiao N, Pardoll DM, Papadopoulos N, Kinzler KW, Eshleman JR, Vogelstein B, Anders RA, Diaz LA Jr. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science 2017; 357(6349): 409\u2013413","journal-title":"Science"}],"container-title":["Frontiers of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11684-017-0581-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-017-0581-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11684-017-0581-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T15:51:53Z","timestamp":1524757913000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11684-017-0581-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,5]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["581"],"URL":"https:\/\/doi.org\/10.1007\/s11684-017-0581-0","relation":{},"ISSN":["2095-0217","2095-0225"],"issn-type":[{"value":"2095-0217","type":"print"},{"value":"2095-0225","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,5]]}}}